EXHIBIT 4.7 WARRANT AGREEMENT FOR "CLASS B WARRANTS" AGREEMENT (this "Agreement") dated as of August 9, 1996, by and between XYTRONYX, INC., a Delaware corporation (the "Company") and AMERICAN STOCK TRANSFER & TRUST COMPANY, as warrant agent (the...Warrant Agreement • June 24th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
CONSULTING AGREEMENTConsulting Agreement • June 27th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • California
Exhibit 4.1 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between Xytronyx, Inc., a Delaware corporation, (the "Company") and the undersigned (the "Subscriber"). W I T N E S...Subscription Agreement • December 15th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 3 TO RIGHTS AGREEMENTRights Agreement • June 27th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances
Lock-Up Agreement -----------------Lock-Up Agreement • December 15th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances
EMPLOYMENT AGREEMENTExecution Copy • February 14th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New Jersey
LICENSE AGREEMENTLicense Agreement • March 23rd, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.50 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between Xytronyx, Inc., a Delaware corporation with its principal offices at 6555 Nancy Ridge Drive, Suite 200,...Subscription Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
LICENSE AGREEMENTLicense Agreement • January 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 4.3 September 11, 1995 New York, New York Paramount Capital, Inc. 375 Park Avenue Suite 1501 New York, New York 10152 Dear Sirs: Xytronyx, Inc., a Delaware corporation (the "Company"), hereby confirms its agreement to retain Paramount Capital,...Xytronyx Inc • December 15th, 1995 • In vitro & in vivo diagnostic substances
SIDE LETTER NO. 1 TO THE PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances
AGREEMENT AND PLAN OF MERGER BETWEEN PROCEPT, INC. PROCEPT ACQUISITION CORP. AND PACIFIC PHARMACEUTICALS, INC. _____________________________ Dated as of December 10, 1998 _____________________________Agreement and Plan of Merger • February 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
XYTRONYX, INC.Agency Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
WARRANT AGREEMENT FOR "CLASS B WARRANTS" AGREEMENT (this "Agreement") dated as of August 9, 1996, by and between XYTRONYX, INC., a Delaware corporation (the "Company") and AMERICAN STOCK TRANSFER & TRUST COMPANY, as warrant agent (the "Warrant...Warrant Agreement • November 13th, 1996 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
INTRODUCTION AGREEMENTIntroduction Agreement • January 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
B-G DEVELOPMENT CORPORATION AND PACIFIC PHARMACEUTICALS, INC.Agency Agreement • July 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.42 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between B-G Development Corporation ("BGDC") Pacific Pharmaceuticals, Inc. ("Pacific" and collectively with BGDC...Subscription Agreement • July 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between B-G Development Corporation ("BGDC") Pacific Pharmaceuticals, Inc. ("Pacific" and collectively with BGDC sometimes referred to as the "Companies"), and the undersigned (the "Subscriber").
February 8, 1999 Pacific Pharmaceuticals, Inc. 6730 Mesa Ridge Road, Suite A San Diego, CA 92121 Re: Amendment to Agreement and Plan of Merger ----------------------------------------- Dear Sirs or Madams: On December 10, 1998, Procept, Inc., a...Pacific Pharmaceuticals Inc • February 12th, 1999 • In vitro & in vivo diagnostic substances
CONSULTING AGREEMENT THIS AGREEMENT, dated as of November 14, 1997 (the "Agreement") is by and between Pacific Pharmaceuticals, Inc., a Delaware corporation having its principal office at 6730 Mesa Ridge Road, Suite A, San Diego, CA 92121 (the...Consulting Agreement • February 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
Contract Year Minimum Quantity of PTM Kits ------------- ---------------------------- 1 * 2 * 3 * 4 * 5 *Exclusive Distribution Agreement for European Territory • February 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
3.3 DEFINITION OF CONTRACT YEAR. As used in this Section, the term "Contract Year" shall mean the period of twelve months commencing on the later to occur of (a) October 1, 1997, or (b) the first day of the calendar month following the Launch Date (as...Exclusive Distribution Agreement • September 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • California
February 27, 1997 BY FACSIMILE H. Laurence Shaw H. Laurence Shaw President and Chief Executive Officer President and Chief Executive Officer Xytronyx, Inc. XYX Acquisition Corp. 6555 Nancy Ridge Drive, Suite 200 6555 Nancy Ridge Drive, Suite 200 San...Xytronyx Inc • June 27th, 1997 • In vitro & in vivo diagnostic substances
For Immediate Release: ---------------------- PROCTER & GAMBLE AND XYTRONYX SIGN AGREEMENT -------------------------------------------- ON A NEW GUM DISEASE TEST ------------------------- May Help Dental Professional Detect Gum Disease Better,...Immediate Release • October 11th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances
